NASDAQ:PPDI PPD Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding PPD Inc Please log in to your account or sign up in order to add this asset to your watchlist. Add Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media PPD Stock Forecast (MarketRank)Analyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.22 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for PPD. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for PPDI. Previous Next 0.0 Dividend Strength Dividend YieldPPD does not currently pay a dividend.Dividend GrowthPPD does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PPDI. Previous Next 1.1 News and Social Media Coverage News SentimentPPD has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.02 average news sentiment score of companies. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PPD insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here Receive PPDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PPD and its competitors with MarketBeat's FREE daily newsletter. Email Address About PPD (NASDAQ:PPDI)Pharmaceutical Product Development, Inc. is a global contract research organization providing drug discovery and development services. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Its development services include preclinical programs and Phase I through Phase IV clinical development services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services. The Company operates in two segments: Development and Discovery Sciences. In May 2009, the Company completed its disposition of its wholly owned subsidiary Piedmont Research Center, LLC. In December 2009, the Company completed its disposition of its wholly owned subsidiary PPD Biomarker Discovery Sciences, LLC. On April 2, 2009, the Company acquired Magen BioSciences, Inc. On April 21, 2009, the Company acquired AbC.R.O., Inc. On November 6, 2009, the Company acquired Excel PharmaStudies, Inc.Read More PPDI Stock News HeadlinesJanuary 22, 2022 | thestreet.comPPDI Inks $3.9 Billion PE Buyout (Update 1)April 16, 2020 | www.businesswire.comAccelerated Enrollment Solutions Launches Patient-Transfer Program to Support Clinical Trial Continuity for Biopharma Companies During COVID-19 PandemicApril 14, 2020 | www.businesswire.comInsights on the L-Carnitine Industry to 2025 - by Product, Process, Application & Region - ResearchAndMarkets.comApril 14, 2020 | finance.yahoo.comWorldwide Licensing Partnering Deals in Pharma, Biotech & Diagnostics, 2014-2020April 14, 2020 | www.businesswire.com$5.6 Bn High-performance Liquid Chromatography (HPLC) Market by Product, Application and Region - Forecast to 2025 - ResearchAndMarkets.comApril 14, 2020 | www.businesswire.comKD Pharma Group & SLA Pharma Initiate Clinical Trial For COVID-19April 14, 2020 | www.marketwatch.comOmega 3 Product Market Latest Report 2020 Global Technology, Development, Trends and Forecasts to 2026April 2, 2020 | www.businesswire.comAccelerated Enrollment Solutions and Science 37 Collaborate to Provide Virtual Trial Access to Patients GloballyMarch 10, 2020 | www.businesswire.comPPD Announces Cancellation of Fireside Chat and Webcast at the Barclays Global Healthcare Conference 2020November 21, 2019 | www.thestreet.comPharmaceutical Product Development Reaches New 52-Week High (PPDI)November 12, 2019 | finance.yahoo.comPPD Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public OfferingOctober 18, 2019 | finance.yahoo.comPPD Repeats as Best CRO at World ADC Awards for Advancing Cancer ResearchOctober 3, 2019 | www.thestreet.comPharmaceutical Product Development Stock Hits New 52-Week High (PPDI)October 3, 2019 | finance.yahoo.comPPD Named a CSO50 Award Winner for Excellence in Information Security Risk ManagementJune 25, 2019 | finance.yahoo.comILiAD Biotechnologies Announces First Patient Enrolled in BPZE1 Pertussis Vaccine Multicenter Phase 2b Clinical TrialApril 17, 2019 | www.businesswire.comPPD Named One of America’s Best Large Employers by ForbesFebruary 28, 2019 | www.fool.comUroGen Pharma Ltd. (URGN) Q4 2018 Earnings Conference Call TranscriptFebruary 27, 2019 | globenewswire.comaTyr Pharma Presents Compelling Preclinical Data Highlighting Potential of ATYR1923 to Regulate Myeloid Cell Biology During Lung InflammationFebruary 27, 2019 | www.businesswire.comPPD Honored for Excellence in Employee Learning and DevelopmentFebruary 25, 2019 | www.marketwatch.comPharmaceutical Contract Manufacturing Market Highest USD 107,004.0 Mn In Healthcare Sector with Huge Business Strategy, Future Demand by 2023February 19, 2019 | globenewswire.comAucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization PartnershipFebruary 14, 2019 | www.bizjournals.comEAS Consulting Group Offers Expertise to Food Firms in New Product DevelopmentFebruary 13, 2019 | www.bizjournals.comCincinnati firm seals development deal with Australian companyFebruary 11, 2019 | www.marketwatch.comUSA Pharmaceutical Directory 2019 - 4,000 Pharmaceutical Companies and 8,000 Executives - ResearchAndMarkets.comFebruary 7, 2019 | www.bizjournals.comGlobal Pharma, Biotech and Diagnostics Co-development Partnering Directory 2018: Headline Value, Upfront, Milestone Payments and Royalty RatesSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:PPDI CUSIPN/A CIK1003124 Webwww.ppdi.com Phone+1-910-2510081FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A PPD Frequently Asked Questions What other stocks do shareholders of PPD own? Based on aggregate information from My MarketBeat watchlists, some companies that other PPD investors own include FT Cboe Vest Gold Target Income ETF (IGLD), Northern Dynasty Minerals (NAK), Chesapeake Energy (CHKAQ), Cannabis Science (CBIS), Cannabis Sativa (CBDS), Citigroup (C), Cannabix Technologies (BLO), Bank of New York Mellon (BK), BHP Group (BHP) and Bank of America (BAC). What is PPD's stock symbol? PPD trades on the NASDAQ under the ticker symbol "PPDI." How can I contact PPD? PPD's mailing address is 929 N Front St, WILMINGTON, NC 28401-3331, United States. The official website for PPD is www.ppdi.com. The healthcare company can be reached via phone at +1-910-2510081. This page (NASDAQ:PPDI) was last updated on 7/2/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
